Alzamend Neuro, Inc. (ALZN) NASDAQ

2.88

-0.0307(-1.05%)

Updated at July 01 11:20AM

Currency In USD

Valuation

Market Cap216.29M
Enterprise Value216.21M
P/E Ratio-3.76
PEG Ratio-0.07
Price/Sales Ratio30.3
Price/Book Ratio4.61
Enterprise/Revenue-13.82
Enterprise/EBITDA0.25

Fiscal Year

Fiscal YearApril 30, 2024
Most Recent QuarterJanuary 31, 2025

Profitability

Profit Margin-55.54
Operating Margin-55.29

Management Effectiveness

Return On Assets-1.01
Return On Equity-4.98

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit-50,740
EBITDA-9.89M
Net Income-9.95M
Diluted EPS-14.7

Balance Sheet

Total Cash3.36M
Total Cash/Share0.61
Total Debt0
Total Debt/Equity0
Current Ratio5.44
Book Value Per Share0.63

Price History

52-Week Change-92.18
52-Week High135.54
52-Week Low2.75
Moving Average 50 Days4.27
Moving Average 200 Days9.5

Statistics

Average Volume1.64M
Shares Outstanding800,954
% Held by Institutions6.35

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split Factor1:9
Last Split DateMay 12, 2025